Genentech, Inc. V. Dr. Reddys Laboratories, Inc. - 2:23-cv-22485

Genentech, Inc. V. Dr. Reddys Laboratories, Inc. (Case No. 2:23-cv-22485), filed on Nov 17, 2023 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
2:23-cv-22485
Filing Date
Nov 17, 2023
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
BIOGEN INC. -
DR. REDDYS LABORATORIES SA -
FRESENIUS KABI DEUTSCHLAND GMBH -
GENENTECH, INC. -
HOFFMANN-LA ROCHE INC. -

Patents Involved

This case involves 15 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)PACER Document
Nov 17, 2023NOTICE of Appearance by MARK M. MAKHAIL on behalf of BIOGEN INC., GENENTECH, INC., HOFFMANN-LA ROCHE INC. (MAKHAIL, MARK) (Entered: 11/17/2023)PACER Document
Nov 17, 2023Corporate Disclosure Statement by BIOGEN INC.. (BETZ, CYNTHIA) (Entered: 11/17/2023)PACER Document
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment
Nov 17, 2023COMPLAINT against DR. REDDYS LABORATORIES LTD., DR. REDDYS LABORATORIES SA, DR. REDDYS LABORATORIES, INC., FRESENIUS KABI DEUTSCHLAND GMBH, FRESENIUS KABI SWISSBIOSIM GMBH, FRESENIUS KABI USA, LLC ( Filing and Admin fee $ 402 receipt number ANJDC-14882103) with JURY DEMAND, Related Case Selected, filed by BIOGEN INC., HOFFMANN-LA ROCHE INC., GENENTECH, INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,485,704, # 2 Exhibit 2 - U.S. Patent No. 7,976,838, # 3 Exhibit 3 - U.S. Patent No. 8,460,895, # 4 Exhibit 4 - U.S. Patent No. 8,512,983, # 5 Exhibit 5 - U.S. Patent No. 8,574,869, # 6 Exhibit 6 - U.S. Patent No. 9,714,293, # 7 Exhibit 7 - U.S. Patent No. 10,017,732, # 8 Exhibit 8 - U.S. Patent No. 10,336,983, # 9 Exhibit 9 - U.S. Patent No. 10,450,379, # 10 Exhibit 10 - U.S. Patent No. 10,654,940, # 11 Exhibit 11 - U.S. Patent No. 10,662,237, # 12 Exhibit 12 - U.S. Patent No. 10,676,710, # 13 Exhibit 13 - U.S. Patent No. 10,759,866, # 14 Exhibit 14 - U.S. Patent No. 10,829,732, # 15 Exhibit 15 - U.S. Patent No. 10,982,003, # 16 Exhibit 16 - Fresenius March 2022 Company Presentation, # 17 Civil Cover Sheet)(BETZ, CYNTHIA) (Entered: 11/17/2023)Attachment